Merck and order recently pulled its arthritis medication, rofecoxib, off the shelves because of recent studies that link the do drugs to increased risk of heart attack and stroke. The FDA had been conducting a airfield that showed an increased amount of cardiovascular problems in those who had been using rofecoxib for eighteen months or more. This decision has outraged many rofecoxib users because many had no idea of the newfound risks associated with rofecoxib. Although Vioxx users did not know of the increased risks of the product, they were aw ar of the potential side do such as abnormal abdominal pain and flu-like symptoms. Vioxx is one example of a drug that was not adequately tested by the FDA and as a result indue longtime users at risk of attracting potentially fatal symptoms.
Both the FDA and Merck and alliance have been blamed for not researching the drug enough, but Merck and Company was only the manucircumstanceurer. The FDA reviews and tests all drugs before putting them out on the open market and therefore deserves most of the blame. The FDA allowed Vioxx to be put on the market in 1999 and within the low gear two years there were tests done by the FDA on Vioxx after complaints about stomach pains but the studies done did not reveal any major risks associated with Vioxx.
The scare part about this story is that the study done that observed these increased risks was intended to determine whether or not Vioxx protected against cancerous intestinal polyps or extra tissue. The fact that the FDA came across this information on accident shows the public how bestial the FDA was on the subject of risks associated with Vioxx. Many, if not all Vioxx users are stunned that the FDA did not take complaints seriously about side...
If you want to get a full information about our service, visit our page: How it works.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.